Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: A microdialysis study-Reference-Cited by-同舟云学术

Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: A microdialysis study

Published:1991-12 Issue:1 Volume:134 Page:88-92
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Janson A.M.,Meana J.J.,Goiny M.,Herrera-Marschitz M.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference17 articles.

1. Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain;Andersson;Med. Biol.,1981

2. Cigarette smoking and Parkinson's disease;Baron;Neurology,1986

3. Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat;Carr;Neurochem. Res.,1989

4. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens;Damsma;Eur. J. Pharmacol.,1989

5. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection;Fuxe;Naunyn-Schmiedeberg's Arch. Pharmacol.,1990

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging preclinical pharmacological targets for Parkinson's disease;Oncotarget;2016-03-15

2. Tobacco nitrosamines as culprits in disease: mechanisms reviewed;Journal of Physiology and Biochemistry;2016-01-14

3. Disease-Modifying Drugs in Parkinson’s Disease;Drugs;2015-11-18

4. Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease;Neuropsychology Review;2015-11-09

5. Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease;Biochemical Pharmacology;2015-10